Illustration: Aïda Amer/Axios

Congress isn't feeling much urgency to help the fledgling market for biosimilars.

Why it matters: Advocates say that they need lawmakers' help soon, or else drugmakers will see biosimilars as a lost cause and the system will lose its only check on the cost of biologics.

Where it stands: Congress' ideas to enhance competition among traditional generics wouldn't do much for biosimilars — less than a dozen of which are on the market.

  • “Different things need to be done for biosimilars because it’s a new industry," said Juliana Reed, president of the Biosimilars Forum.
  • Lawmakers "don’t seem to appreciate" how many of the drugs have been stymied by intellectual property challenges or backwards commercial incentives, said Chip Davis, president and CEO of the Association for Accessible Medicines.

What they're saying: Both groups want Congress to alter Medicare's financial incentives to help bolster biosimilars. Davis' group also wants it to speed up patent lawsuits.

The other side: "It’s unclear that anything actually needs to be done on biosimilars as the law is still in its nascent stages," said a senior GOP aide working on drug prices.

Where it stands: The Senate health committee recently proposed accelerating the biosimilar approval process. Sens. John Barrasso and Sherrod Brown also said they'll have bills coming soon.

Yes, but: "I guess the answer ought to be yes. But I don’t know all of the issues yet," Finance Committee Chairman Chuck Grassley said when asked about increasing biosimilar competition.

Go deeper: How cheaper drugs are kept off the market

Go deeper

Updated 8 mins ago - Politics & Policy

Ohio Gov. Mike DeWine tests negative for coronavirus after positive result

Photo: Justin Merriman/Getty Images

Ohio Gov. Mike DeWine (R) tested negative for the coronavirus after initially testing positive earlier Thursday, his office announced.

Why it matters: 73-year-old DeWine was set to meet President Trump Thursday on the tarmac at an airport in Cleveland and was tested as part of standard protocol.

Updated 18 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 18,996,008 — Total deaths: 712,476— Total recoveries — 11,478,835Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 4,877,115 — Total deaths: 159,990 — Total recoveries: 1,598,624 — Total tests: 59,652,675Map.
  3. Politics: Pelosi rips GOP over stimulus negotiations: "Perhaps you mistook them for somebody who gives a damn" — Ohio Gov. Mike DeWine tests positive.
  4. Public health: Majority of Americans say states reopened too quicklyFauci says task force will examine aerosolized spread Study finds COVID-19 antibodies prevalent in NYC health care workers.
  5. Business: The health care sector imploded in Q2More farmers are declaring bankruptcyJuly's jobs report could be an inflection point for the recovery.
  6. Sports: Where college football's biggest conferences stand on playing.

Trump issues order banning TikTok if not sold within 45 days

Illustration: Aïda Amer/Axios

Americans and U.S. companies will be banned from making transactions with ByteDance, the Chinese owner of TikTok, in 45 days, according to a new executive order President Trump issued Thursday evening.

The big picture: Last week Trump announced his intention to ban TikTok but said he'd leave a 45-day period for Microsoft or other U.S.-based suitors to try to close a deal to acquire the popular video-sharing app.